Compare DMRA & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DMRA | SANA |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2020 | 2021 |
| Metric | DMRA | SANA |
|---|---|---|
| Price | $24.58 | $3.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $46.00 | $7.60 |
| AVG Volume (30 Days) | 272.3K | ★ 2.7M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.24 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.50 | $1.32 |
| 52 Week High | $27.68 | $6.55 |
| Indicator | DMRA | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 50.29 | 47.42 |
| Support Level | $22.92 | $3.16 |
| Resistance Level | $27.68 | $3.36 |
| Average True Range (ATR) | 3.24 | 0.20 |
| MACD | 0.31 | 0.03 |
| Stochastic Oscillator | 76.83 | 68.66 |
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.